Skip to main content

Table 1.

Comparison between preoperative and postoperative (total gastrectomy) pharmacokinetic parameters in the plasma of six patients receiving 40 mg/m2 S‐1 orally

Parameter Time of test Tegafur 5‐Fluorouracil CDHP OXO FUH2 FBAL
T1/2 (h) Preoperative     8.7 ± 4.2   2.2 ± 0.4   2.6 ± 0.6   2.8 ± 1.7 NC NC
Postoperative     8.1 ± 1.8   2.3 ± 0.3   3.0 ± 0.6   3.5 ± 1.7 NC NC
Cmax (ng/mL) Preoperative   2520 ± 794  125 ± 57  282 ± 69   55 ± 20  148 ± 77  62 ± 20
Postoperative   2715 ± 332  166 ± 77**  453 ± 224  210 ± 184*  156 ± 62  72 ± 23
Tmax (h) Preoperative     2.5 ± 1.2   4.0 ± 0.0   3.0 ± 1.1   3.0 ± 1.1   7.3 ± 2.1  8.7 ± 2.1
Postoperative     1.2 ± 0.4   3.3 ± 1.0   1.8 ± 0.4   3.0 ± 1.1   6.0 ± 0.0  8.0 ± 2.2
AUC1–10h (ng·h/mL) Preoperative 16 726 ± 3844  680 ± 298 1389 ± 398  276 ± 113 1055 ± 553 405 ± 156
Postoperative 17 726 ± 3368 1030 ± 501** 2163 ± 933** 1004 ± 904* 1153 ± 454 546 ± 184*
*

P < 0.05 and

**

P < 0.01 compared to preoperative values tested using the paired Student's t‐test. AUC1–10h, the area under the curve until 10 h after S‐1 administration; CDHP, 5‐chloro‐2,4‐dihydroxypyridine; Cmax, the maximum concentration; FBAL, α‐fluoro‐β‐alanine; FUH2, dihydrofluorouracil; NC, not calculated; OXO, potassium oxonate; T1/2, the half‐life; Tmax, the time required to reach Cmax.